Agenus Inc reports results for the quarter ended September 30 - Earnings Summary

Agenus

12/11/2024 15:28

* Agenus Inc  AGEN.OQ  reported a quarterly adjusted loss of
$3.08​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-3.20.  The mean expectation of five analysts for the
quarter was for a loss of $2.33 per share. Wall Street expected
results to range from $-2.89 to -90 cents per share.
    * Revenue rose 3.3% to $25.11 million from a year ago;
analysts
expected $33.48 million. 
    * Agenus Inc's reported EPS for the quarter was a loss of
$3.08​.
    * The company reported a quarterly loss of $67.21 million.
    * Agenus Inc shares had fallen by 28.8% this quarter and
lost 76.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Agenus Inc is
7.50 
This summary was machine generated from LSEG data November 12 at
03:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -2.33          -3.08          Missed
 Jun. 30 2024      -1.44          -2.52          Missed
 Mar. 31 2024      -3.22          -3.04          Beat
 Dec. 31 2023      -1.05          -2.60          Missed